Sublingual and oral zolpidem for insomnia disorder: a 3-month randomized trial
Laura S Castro 1, Leonardo J Otuyama 1, Cristiane Fumo-Dos-Santos 1, Sergio Tufik 1, Dalva Poyares 1
Laura S Castro 1, Leonardo J Otuyama 1, Cristiane Fumo-Dos-Santos 1, Sergio Tufik 1, Dalva Poyares 1
Kette D Valente 1, Rosa Hasan, Stella M Tavares, Wagner F Gattaz
G.C. de Campos, E. de Almeida Macedo, A.M. Kummer, M. Papaleo Rosim, M. Millan Fachi, L.L. Auletta
Departamento de Ortopedia, Reumatologia e Traumatologia, Universidade Estadual de Campinas, Campinas, SP, Brazil. arthur.kummer@ncfarma.com.br
Plapler PG, Scheinberg MA, Ecclissato Cda C, Bocchi de Oliveira MF, Amazonas RB.
Drug Des Devel Ther. 2016 Jun 17;10:1987-93. doi: 10.2147/DDDT.S97756. eCollection 2016.
Wandalsen GF, Miranda C, Ensina LF, Sano F, Amazonas RB, Silva JMD, Solé D.
Braz J Otorhinolaryngol. 2017 Nov-Dec;83(6):633-639. doi: 10.1016/j.bjorl.2016.08.009. Epub 2016 Sep 13.
Scheinberg M, Pott Júnior H, Macêdo EA, Bocchi de Oliveira MF, Ecclissato C, Amazonas RB.
Drug Des Devel Ther. 2018 Sep 6;12:2775-2783. doi: 10.2147/DDDT.S172068. eCollection 2018.